GAMMA-GLUTAMYL TRANSPEPTIDASE (GGT) - ANVISA Registration 10287411398

Access comprehensive regulatory information for GAMMA-GLUTAMYL TRANSPEPTIDASE (GGT) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10287411398 and manufactured by ROCHE DIAGNOSTICS GMBH. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS INC., DOLES REAGENTES E EQUIPAMENTOS PARA LABORATORIOS LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10287411398
Registration Details
ANVISA Registration Number: 10287411398
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

GGT-2 (Gama-Glutamyltransferase ver.2 - Standardized against IFCC / Szasz)_cobas c
Risk Class II

Registration Details

10287411398

25351204891201931

30280358000186

Company Information

Germany
PT: ALEMANHA

Dates and Status

Jul 01, 2019

VIGENTE

09/18/2025 19:00:01